Exact Sciences announces third quarter 2021 results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Needham Starts NeoVolta (NEOV) at Buy
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- KKR launches Helix with over $10 billion to build AI infrastructure
Exact Sciences (EXAS) Misses Q3 EPS by 12c, Revenue Beats, Offers FY Guidance
November 2, 2021 4:26 PM EDTExact Sciences (NASDAQ: EXAS) reported Q3 EPS of ($0.97), $0.12 worse than the analyst estimate of ($0.85). Revenue for the quarter came in at $456.4 million versus the consensus estimate of $430.55 million.
GUIDANCE:
Exact Sciences sees 2021 revenue of $1.72-1.74 billion, versus the consensus of $1.73... More
